Selective Inhibitors of Nuclear Export (SINE) for Gemcitabine Resistant Pancreatic Cancer

被引：0
|
作者：
Azmi, A. S.
Kauffman, M. [1 ]
Shacham, S. [1 ]
Mohammad, R. M. [2 ]
机构：
[1] Karyopharm, Boston, MA USA
[2] KCI, Dept Oncol, Detroit, MI USA
来源：
PANCREAS | 2013年 / 42卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1338 / 1338
页数：1
相关论文
共 50 条
  • [41] CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce the incidence of tumor spreading and improve overall survival in preclinical models of prostate cancer.
    Gravina, Giovanni Luca
    Tortoreto, Monica
    Mancini, Andrea
    Muzi, Paola
    Ventura, Luca
    D'ascenzo, Sandra
    Addis, Alessandro
    Landesman, Yosef
    McCaulev, Dilara
    Dolo, Vincenza
    Kauffman, Michael
    Shacham, Sharon
    Zaffaroni, Nadia
    Festuccia, Claudio
    CANCER RESEARCH, 2013, 73 (08)
  • [42] Selective inhibitors of nuclear export (SINEs) in myeloma: breakthrough or bust?
    Nishihori, Taiga
    Baz, Rachid
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (02) : 113 - 115
  • [43] KPT-SINE (Selective Inhibitors of Nuclear Export) induce apoptosis in colon cancer cells in-vitro and in-vivo through nuclear localization of Tumor Suppressor Proteins (TSPs)
    Senapedis, William
    Landesman, Yossi
    St-Martin, Jean
    Kashyap, Trinayan
    Plamondon, Louis
    Sandanayaka, Vincent
    Shechter, Sharon
    Froim, Doriana
    McCauley, Dilara
    Nir, Raphael
    Williams, Jennifer L.
    Kauffman, Michael
    Shacham, Sharon
    CANCER RESEARCH, 2012, 72
  • [44] CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
    Inoue, Hiromi
    Kauffman, Michael
    Shacham, Sharon
    Landesman, Yosef
    Yang, Joy
    Evans, Christopher P.
    Weiss, Robert H.
    JOURNAL OF UROLOGY, 2013, 189 (06): : 2317 - 2326
  • [45] Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds
    Crochiere, Marsha
    Kashyap, Trinayan
    Kalid, Ori
    Shechter, Sharon
    Klebanov, Boris
    Senapedis, William
    Saint-Martin, Jean-Richard
    Landesman, Yosef
    BMC CANCER, 2015, 15
  • [46] Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds
    Marsha Crochiere
    Trinayan Kashyap
    Ori Kalid
    Sharon Shechter
    Boris Klebanov
    William Senapedis
    Jean-Richard Saint-Martin
    Yosef Landesman
    BMC Cancer, 15
  • [47] Targeting Nuclear Export Machinery for Pancreatic Cancer Therapy
    Azmi, A. S.
    Shacham, S.
    Aboukameel, A.
    Bao, B.
    Kauffman, M.
    Sarkar, F. H.
    Mohammad, R. M.
    PANCREAS, 2012, 41 (08) : 1348 - 1348
  • [48] Synergistic antitumor effect of selinexor, a selective inhibitor of nuclear export (SINE) compound and trastuzumab in a mouse model of breast cancer
    Elloul, Sivan
    Chang, Hua Hua
    Klebanov, Boris
    Kashyap, Trinayan
    Werman, Maxwell
    Lee, Margaret
    Landesman, Yosef
    Shacham, Sharon
    Kauffman, Michael
    Friedlander, Sharon Y.
    CANCER RESEARCH, 2016, 76
  • [49] Eltanexor (KPT-8602), a second-generation selective inhibitor of nuclear export (SINE) compound, in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Zhang, Jingsong
    Chism, David D.
    Tagawa, Scott T.
    Monk, Paul
    Alter, Robert S.
    Reichman, William
    Senapedis, William
    Baloglu, Erkan
    Shacham, Sharon
    Kauffman, Michael G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [50] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 113 - 123
12345